speb/financial-data huggingface dataset:
VET income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 65638000.00
VET balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 123505000.00
VET income_statement (annual, 2022-12-31) — General And Administrative Expense: 102067000.00
VET balance_sheet (annual, 2022-12-31) — Gross PPE: 12535091000.00
VET income_statement (annual, 2022-12-31) — Gross Profit: 2593243000.00
VET balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 162843000.00
VET cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 144814000.00
VET balance_sheet (annual, 2022-12-31) — Income Tax Payable: 341698000.00
VET income_statement (annual, 2022-12-31) — Interest Expense: 82858000.00
VET income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 82858000.00
VET cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 75042000.00
VET balance_sheet (annual, 2022-12-31) — Inventory: 19657000.00
VET balance_sheet (annual, 2022-12-31) — Invested Capital: 4482409000.00
VET cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1059292000.00
VET balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 56366000.00
VET balance_sheet (annual, 2022-12-31) — Investments And Advances: 56366000.00
VET cash_flow (annual, 2022-12-31) — Issuance Of Debt: 499037000.00
VET balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 51507000.00
VET balance_sheet (annual, 2022-12-31) — Long Term Debt: 1081351000.00
VET balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1132858000.00
VET cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 499037000.00
VET cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1143036000.00
VET balance_sheet (annual, 2022-12-31) — Long Term Provisions: 1087757000.00
VET cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -510309000.00
VET cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -71659000.00
VET balance_sheet (annual, 2022-12-31) — Net Debt: 1067515000.00
VET cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 84464000.00
VET income_statement (annual, 2022-12-31) — Net Income: 1313062000.00
VET income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 1313062000.00
VET income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 1313062000.00
VET income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 1313062000.00
VET income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 1313062000.00
VET cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 1313062000.00
VET income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 1313062000.00
VET income_statement (annual, 2022-12-31) — Net Interest Income: -82858000.00
VET cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -23282000.00
VET cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -643999000.00
VET cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -643999000.00
VET income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -82858000.00
VET cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 26116000.00
VET balance_sheet (annual, 2022-12-31) — Net PPE: 5962115000.00
VET cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -551817000.00
VET balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 3401058000.00
VET balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 125533000.00
VET balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 477340000.00
VET balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 125533000.00
VET balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 477340000.00
VET income_statement (annual, 2022-12-31) — Normalized EBITDA: 2453359000.00
VET income_statement (annual, 2022-12-31) — Normalized Income: 1148068454.89
VET cash_flow (annual, 2022-12-31) — Operating Cash Flow: 1814220000.00
VET cash_flow (annual, 2022-12-31) — Operating Gains Losses: -456337000.00
VET income_statement (annual, 2022-12-31) — Operating Income: 1865076000.00
VET income_statement (annual, 2022-12-31) — Operating Revenue: 3721228000.00
VET balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 163226618.00
VET balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 55845000.00
VET balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 123505000.00
VET income_statement (annual, 2022-12-31) — Other Gand A: 57677000.00
VET income_statement (annual, 2022-12-31) — Other Income Expense: 268881000.00
VET cash_flow (annual, 2022-12-31) — Other Non Cash Items: 22489000.00
VET income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 11149000.00
VET income_statement (annual, 2022-12-31) — Other Operating Expenses: 626100000.00
VET balance_sheet (annual, 2022-12-31) — Other Properties: 12058520000.00
VET balance_sheet (annual, 2022-12-31) — Payables: 836200000.00
VET balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 836200000.00
VET balance_sheet (annual, 2022-12-31) — Prepaid Assets: 144459000.00
VET income_statement (annual, 2022-12-31) — Pretax Income: 2051099000.00
VET balance_sheet (annual, 2022-12-31) — Properties: 476571000.00
VET cash_flow (annual, 2022-12-31) — Purchase Of Business: -510309000.00
VET cash_flow (annual, 2022-12-31) — Purchase Of Investment: -23282000.00
VET cash_flow (annual, 2022-12-31) — Purchase Of PPE: -551817000.00
VET balance_sheet (annual, 2022-12-31) — Receivables: 373651000.00
VET income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1127985000.00
VET income_statement (annual, 2022-12-31) — Reconciled Depreciation: 577134000.00
VET cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1143036000.00
VET cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -71659000.00
VET income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
VET balance_sheet (annual, 2022-12-31) — Retained Earnings: -1001650000.00
VET income_statement (annual, 2022-12-31) — Salaries And Wages: 44390000.00
VET cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
VET income_statement (annual, 2022-12-31) — Selling General And Administration: 102067000.00
VET balance_sheet (annual, 2022-12-31) — Share Issued: 163226618.00
VET income_statement (annual, 2022-12-31) — Special Income Charges: 192094000.00
VET cash_flow (annual, 2022-12-31) — Stock Based Compensation: 44390000.00
VET balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3401058000.00
VET balance_sheet (annual, 2022-12-31) — Tangible Book Value: 3401058000.00
VET income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 92738454.89
VET income_statement (annual, 2022-12-31) — Tax Provision: 738037000.00
VET income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.36
VET balance_sheet (annual, 2022-12-31) — Total Assets: 6991058000.00
VET balance_sheet (annual, 2022-12-31) — Total Capitalization: 4482409000.00
VET balance_sheet (annual, 2022-12-31) — Total Debt: 1132858000.00
VET balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3401058000.00
VET income_statement (annual, 2022-12-31) — Total Expenses: 1856152000.00
VET balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3590000000.00
VET balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 6276612000.00
VET balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 2697955000.00
VET balance_sheet (annual, 2022-12-31) — Total Tax Payable: 341698000.00
VET income_statement (annual, 2022-12-31) — Total Unusual Items: 257732000.00
VET income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 257732000.00
VET balance_sheet (annual, 2022-12-31) — Working Capital: -177599000.00
VET income_statement (annual, 2022-12-31) — Write Off: -192094000.00
VET income_statement (annual, 2023-12-31) — +Operating Expense: 803896000.00
VET income_statement (annual, 2023-12-31) — +Total Revenue: 2199555000.00
VET balance_sheet (annual, 2023-12-31) — Accounts Payable: 380370000.00
VET balance_sheet (annual, 2023-12-31) — Accounts Receivable: 242926000.00
VET balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -8317713000.00
VET balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 43348000.00
VET cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 1016094000.00
VET income_statement (annual, 2023-12-31) — Basic Average Shares: 163719000.00
VET income_statement (annual, 2023-12-31) — Basic EPS: -1.45
VET cash_flow (annual, 2023-12-31) — Beginning Cash Position: 13836000.00
VET cash_flow (annual, 2023-12-31) — Capital Expenditure: -732472000.00
VET balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 33001000.00
VET balance_sheet (annual, 2023-12-31) — Capital Stock: 4142566000.00
VET balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 141456000.00
VET balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 141456000.00
VET cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -62080000.00
VET balance_sheet (annual, 2023-12-31) — Cash Equivalents: 661000.00
VET balance_sheet (annual, 2023-12-31) — Cash Financial: 140795000.00
VET cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -320336000.00
VET cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -576435000.00
VET cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 1024528000.00
VET cash_flow (annual, 2023-12-31) — Change In Working Capital: -61117000.00
VET cash_flow (annual, 2023-12-31) — Changes In Cash: 127757000.00
VET balance_sheet (annual, 2023-12-31) — Common Stock: 4142566000.00
VET balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3031648000.00
VET cash_flow (annual, 2023-12-31) — Common Stock Payments: -94838000.00
VET income_statement (annual, 2023-12-31) — Cost Of Revenue: 1081313000.00
VET balance_sheet (annual, 2023-12-31) — Current Assets: 823514000.00
VET balance_sheet (annual, 2023-12-31) — Current Liabilities: 696074000.00
VET cash_flow (annual, 2023-12-31) — Deferred Income Tax: -190193000.00
VET cash_flow (annual, 2023-12-31) — Deferred Tax: -190193000.00
VET cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 712619000.00
VET balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 21050000.00
VET income_statement (annual, 2023-12-31) — Diluted Average Shares: 163719000.00
VET income_statement (annual, 2023-12-31) — Diluted EPS: -1.45
VET income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -237587000.00
VET balance_sheet (annual, 2023-12-31) — Dividends Payable: 16227000.00
VET income_statement (annual, 2023-12-31) — EBIT: -193070000.00
VET income_statement (annual, 2023-12-31) — EBITDA: 519549000.00
VET cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -137000.00
VET cash_flow (annual, 2023-12-31) — End Cash Position: 141456000.00
VET balance_sheet (annual, 2023-12-31) — Financial Assets: 76107000.00
VET cash_flow (annual, 2023-12-31) — Financing Cash Flow: -320336000.00
VET balance_sheet (annual, 2023-12-31) — Finished Goods: 57333000.00
VET cash_flow (annual, 2023-12-31) — Free Cash Flow: 292056000.00
VET cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -179707000.00
VET cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 352367000.00
VET income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: -352367000.00
VET income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 421978000.00
VET balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: 109302000.00
VET income_statement (annual, 2023-12-31) — General And Administrative Expense: 123472000.00
VET balance_sheet (annual, 2023-12-31) — Gross PPE: 13398601000.00
VET income_statement (annual, 2023-12-31) — Gross Profit: 1118242000.00
VET balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 313792000.00
VET cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 306911000.00
VET balance_sheet (annual, 2023-12-31) — Income Tax Payable: 298745000.00
VET income_statement (annual, 2023-12-31) — Interest Expense: 85212000.00
VET income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 85212000.00
VET cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 84471000.00
VET balance_sheet (annual, 2023-12-31) — Inventory: 57333000.00
VET balance_sheet (annual, 2023-12-31) — Invested Capital: 3945663000.00
VET cash_flow (annual, 2023-12-31) — Investing Cash Flow: -576435000.00
VET balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 73261000.00
VET balance_sheet (annual, 2023-12-31) — Investments And Advances: 73261000.00
VET cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
VET balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 33001000.00
VET balance_sheet (annual, 2023-12-31) — Long Term Debt: 914015000.00
VET balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 947016000.00
VET cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
VET cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -163418000.00
VET balance_sheet (annual, 2023-12-31) — Long Term Provisions: 1159063000.00
VET cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 54726000.00
VET cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -94838000.00
VET balance_sheet (annual, 2023-12-31) — Net Debt: 772559000.00
VET cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -12438000.00
VET income_statement (annual, 2023-12-31) — Net Income: -237587000.00
VET income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -237587000.00
VET income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -237587000.00
VET income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -237587000.00
VET income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -237587000.00
VET cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -237587000.00
VET income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -237587000.00
VET income_statement (annual, 2023-12-31) — Net Interest Income: -85212000.00
VET cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -21603000.00
VET cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -163418000.00
VET cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -163418000.00
VET income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -85212000.00
VET cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -19367000.00
VET balance_sheet (annual, 2023-12-31) — Net PPE: 5080888000.00
VET cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -535465000.00
VET balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 3031648000.00
VET balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 182051000.00
VET balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 380970000.00
VET balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 182051000.00
VET balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 380970000.00
VET income_statement (annual, 2023-12-31) — Normalized EBITDA: 1026545000.00
VET income_statement (annual, 2023-12-31) — Normalized Income: 195267653.38
VET cash_flow (annual, 2023-12-31) — Operating Cash Flow: 1024528000.00
VET cash_flow (annual, 2023-12-31) — Operating Gains Losses: 160222000.00
VET income_statement (annual, 2023-12-31) — Operating Income: 314346000.00
VET income_statement (annual, 2023-12-31) — Operating Revenue: 2199555000.00
VET balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 162271071.00
VET balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 732000.00
VET balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: 109302000.00
VET income_statement (annual, 2023-12-31) — Other Gand A: 80716000.00
VET income_statement (annual, 2023-12-31) — Other Income Expense: -507416000.00
VET cash_flow (annual, 2023-12-31) — Other Non Cash Items: -418266000.00
VET income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -420000.00
VET income_statement (annual, 2023-12-31) — Other Operating Expenses: 680424000.00
VET balance_sheet (annual, 2023-12-31) — Other Properties: 12966256000.00
VET balance_sheet (annual, 2023-12-31) — Payables: 695342000.00
VET balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 695342000.00
VET balance_sheet (annual, 2023-12-31) — Prepaid Assets: 68007000.00
VET income_statement (annual, 2023-12-31) — Pretax Income: -278282000.00
VET balance_sheet (annual, 2023-12-31) — Properties: 432345000.00
VET cash_flow (annual, 2023-12-31) — Purchase Of Business: -142281000.00
VET cash_flow (annual, 2023-12-31) — Purchase Of Investment: -21603000.00
VET cash_flow (annual, 2023-12-31) — Purchase Of PPE: -732472000.00
VET balance_sheet (annual, 2023-12-31) — Receivables: 242926000.00
VET income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1081313000.00
VET income_statement (annual, 2023-12-31) — Reconciled Depreciation: 712619000.00
VET cash_flow (annual, 2023-12-31) — Repayment Of Debt: -163418000.00
VET cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -94838000.00
VET income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: -439487000.00
VET balance_sheet (annual, 2023-12-31) — Retained Earnings: -1263568000.00
VET income_statement (annual, 2023-12-31) — Salaries And Wages: 42756000.00
VET cash_flow (annual, 2023-12-31) — Sale Of Business: 197007000.00
VET cash_flow (annual, 2023-12-31) — Sale Of PPE: 197007000.00
VET income_statement (annual, 2023-12-31) — Selling General And Administration: 123472000.00
VET balance_sheet (annual, 2023-12-31) — Share Issued: 162271071.00
VET income_statement (annual, 2023-12-31) — Special Income Charges: -928974000.00
VET cash_flow (annual, 2023-12-31) — Stock Based Compensation: 42756000.00
VET balance_sheet (annual, 2023-12-31) — Stockholders Equity: 3031648000.00
VET balance_sheet (annual, 2023-12-31) — Tangible Book Value: 3031648000.00
VET income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -74141346.62
VET income_statement (annual, 2023-12-31) — Tax Provision: -40695000.00
VET income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.15
VET balance_sheet (annual, 2023-12-31) — Total Assets: 6235821000.00
VET balance_sheet (annual, 2023-12-31) — Total Capitalization: 3945663000.00
VET balance_sheet (annual, 2023-12-31) — Total Debt: 947016000.00
VET balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 3031648000.00
VET income_statement (annual, 2023-12-31) — Total Expenses: 1885209000.00
VET balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 3204173000.00
VET balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 5412307000.00
VET balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 2508099000.00
VET balance_sheet (annual, 2023-12-31) — Total Tax Payable: 298745000.00
VET income_statement (annual, 2023-12-31) — Total Unusual Items: -506996000.00
VET income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -506996000.00
VET balance_sheet (annual, 2023-12-31) — Working Capital: 127440000.00
VET income_statement (annual, 2023-12-31) — Write Off: 1016094000.00
VET cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: 0.00
VET income_statement (quarterly, 2024-09-30) — Basic Average Shares: 156624000.00
VET income_statement (quarterly, 2024-09-30) — Basic EPS: 0.33
VET cash_flow (quarterly, 2024-09-30) — Capital Expenditure Reported: -121269000.00
VET cash_flow (quarterly, 2024-09-30) — Common Stock Dividend Paid: -18981000.00
VET income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 157502000.00
VET income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.33
VET cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 0.00
VET income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: 0.00
VET cash_flow (quarterly, 2024-09-30) — Net Short Term Debt Issuance: 0.00
VET income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
VET cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
VET cash_flow (quarterly, 2024-09-30) — Short Term Debt Issuance: 0.00
VET income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
VET income_statement (annual, 2024-12-31) — +Operating Expense: 702539000.00
VET income_statement (annual, 2024-12-31) — +Total Revenue: 1639336000.00
VET balance_sheet (annual, 2024-12-31) — Accounts Payable: 425410000.00
VET balance_sheet (annual, 2024-12-31) — Accounts Receivable: 298493000.00
VET balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -8978087000.00
VET balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -8978087000.00
VET balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 45225000.00
VET cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
VET balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 78862000.00
VET balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 78862000.00
VET income_statement (annual, 2024-12-31) — Basic Average Shares: 158068000.00
VET income_statement (annual, 2024-12-31) — Basic EPS: -0.30
VET cash_flow (annual, 2024-12-31) — Beginning Cash Position: 141456000.00
VET cash_flow (annual, 2024-12-31) — Capital Expenditure: -622980000.00
VET cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -205916000.00
VET balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 54991000.00
VET balance_sheet (annual, 2024-12-31) — Capital Stock: 3918898000.00
VET balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 131730000.00
VET balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 131730000.00
VET cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -73033000.00
VET balance_sheet (annual, 2024-12-31) — Cash Equivalents: 6792000.00
VET balance_sheet (annual, 2024-12-31) — Cash Financial: 124938000.00
VET cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -344084000.00
VET cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -634868000.00
VET cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 967751000.00
VET cash_flow (annual, 2024-12-31) — Change In Working Capital: -182698000.00
VET cash_flow (annual, 2024-12-31) — Changes In Cash: -11201000.00
VET balance_sheet (annual, 2024-12-31) — Common Stock: 3918898000.00
VET balance_sheet (annual, 2024-12-31) — Common Stock Equity: 2810989000.00
VET cash_flow (annual, 2024-12-31) — Common Stock Payments: -140707000.00
VET income_statement (annual, 2024-12-31) — Cost Of Revenue: 749741000.00
VET balance_sheet (annual, 2024-12-31) — Current Assets: 582326000.00
VET balance_sheet (annual, 2024-12-31) — Current Liabilities: 664178000.00
VET cash_flow (annual, 2024-12-31) — Deferred Income Tax: -37991000.00
VET cash_flow (annual, 2024-12-31) — Deferred Tax: -37991000.00
VET cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 683240000.00
VET balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 86036000.00
VET income_statement (annual, 2024-12-31) — Diluted Average Shares: 158068000.00
VET income_statement (annual, 2024-12-31) — Diluted EPS: -0.30
VET income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -46739000.00
VET balance_sheet (annual, 2024-12-31) — Dividends Payable: 18521000.00
VET balance_sheet (quarterly, 2024-12-31) — Dividends Payable: 18521000.00
VET income_statement (annual, 2024-12-31) — EBIT: 14687000.00
VET income_statement (annual, 2024-12-31) — EBITDA: 697927000.00
VET cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 1475000.00
VET cash_flow (annual, 2024-12-31) — End Cash Position: 131730000.00
VET balance_sheet (annual, 2024-12-31) — Financial Assets: 13927000.00
VET cash_flow (annual, 2024-12-31) — Financing Cash Flow: -344084000.00
VET balance_sheet (annual, 2024-12-31) — Finished Goods: 40694000.00
VET cash_flow (annual, 2024-12-31) — Free Cash Flow: 344771000.00
VET cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 452858000.00
VET cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
VET income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 0.00
VET income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 0.00
VET income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -159268000.00
VET balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 135847000.00
VET income_statement (annual, 2024-12-31) — General And Administrative Expense: 103940000.00
VET balance_sheet (annual, 2024-12-31) — Gross PPE: 14220834000.00
VET income_statement (annual, 2024-12-31) — Gross Profit: 889595000.00
VET balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 40312000.00
VET cash_flow (annual, 2024-12-31) — Income Tax Paid Supplemental Data: 263048000.00
VET cash_flow (quarterly, 2024-12-31) — Income Tax Paid Supplemental Data: 47960000.00
VET balance_sheet (annual, 2024-12-31) — Income Tax Payable: 113715000.00
VET income_statement (annual, 2024-12-31) — Interest Expense: 84606000.00
VET income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 84606000.00
VET cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 85649000.00
VET balance_sheet (annual, 2024-12-31) — Inventory: 40694000.00
VET balance_sheet (annual, 2024-12-31) — Invested Capital: 3774445000.00
VET cash_flow (annual, 2024-12-31) — Investing Cash Flow: -634868000.00
VET balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 78862000.00
VET balance_sheet (annual, 2024-12-31) — Investments And Advances: 78862000.00
VET cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
VET balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 54991000.00
VET balance_sheet (annual, 2024-12-31) — Long Term Debt: 963456000.00
VET balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1018447000.00
VET cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
VET cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -133100000.00
VET balance_sheet (annual, 2024-12-31) — Long Term Provisions: 1171130000.00
VET cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -12728000.00
VET cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -140707000.00
VET balance_sheet (annual, 2024-12-31) — Net Debt: 831726000.00
VET cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 58471000.00
VET income_statement (annual, 2024-12-31) — Net Income: -46739000.00
VET income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -46739000.00
VET income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -96169000.00
VET income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 49430000.00
VET income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -46739000.00
VET income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -96169000.00
VET cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -46739000.00
VET income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -46739000.00
VET income_statement (annual, 2024-12-31) — Net Interest Income: -84606000.00
VET cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -9373000.00
VET cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
VET cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -133100000.00
VET cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -133100000.00
VET income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -84606000.00
VET cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 2756000.00
VET cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 10213000.00
VET balance_sheet (annual, 2024-12-31) — Net PPE: 5242747000.00
VET cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -622980000.00
VET cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
VET balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 2810989000.00
VET balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 197714000.00
VET balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 364796000.00
VET balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 197714000.00
VET balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 364796000.00
VET income_statement (annual, 2024-12-31) — Normalized EBITDA: 857195000.00
VET income_statement (annual, 2024-12-31) — Normalized Income: 39208800.00
VET cash_flow (annual, 2024-12-31) — Operating Cash Flow: 967751000.00
VET cash_flow (annual, 2024-12-31) — Operating Gains Losses: 511329000.00
VET income_statement (annual, 2024-12-31) — Operating Income: 187056000.00
VET income_statement (annual, 2024-12-31) — Operating Revenue: 1639336000.00
VET balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 154344353.00
VET balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 106532000.00
VET balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 135847000.00
VET income_statement (annual, 2024-12-31) — Other Gand A: 74010000.00
VET income_statement (annual, 2024-12-31) — Other Income Expense: -172369000.00
VET cash_flow (annual, 2024-12-31) — Other Non Cash Items: 25041000.00
VET income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -13101000.00
VET income_statement (annual, 2024-12-31) — Other Operating Expenses: 598599000.00
VET balance_sheet (annual, 2024-12-31) — Other Properties: 13760503000.00
VET balance_sheet (quarterly, 2024-12-31) — Other Properties: 13760503000.00
VET balance_sheet (annual, 2024-12-31) — Payables: 557646000.00
VET balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 557646000.00
VET balance_sheet (annual, 2024-12-31) — Prepaid Assets: 71097000.00
VET income_statement (annual, 2024-12-31) — Pretax Income: -69919000.00
VET balance_sheet (annual, 2024-12-31) — Properties: 460331000.00
VET cash_flow (annual, 2024-12-31) — Purchase Of Business: -12728000.00
VET cash_flow (annual, 2024-12-31) — Purchase Of Investment: -9373000.00
VET cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: 0.00
VET cash_flow (annual, 2024-12-31) — Purchase Of PPE: -622980000.00
VET balance_sheet (annual, 2024-12-31) — Receivables: 298493000.00
VET income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 749741000.00
VET income_statement (annual, 2024-12-31) — Reconciled Depreciation: 683240000.00
VET cash_flow (annual, 2024-12-31) — Repayment Of Debt: -133100000.00
VET cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -140707000.00
VET income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
VET income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
VET balance_sheet (annual, 2024-12-31) — Retained Earnings: -1288981000.00
VET income_statement (annual, 2024-12-31) — Salaries And Wages: 29930000.00
VET cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
VET cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
VET cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
VET cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
VET income_statement (annual, 2024-12-31) — Selling General And Administration: 103940000.00
VET balance_sheet (annual, 2024-12-31) — Share Issued: 154344353.00
VET income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
VET income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
VET cash_flow (annual, 2024-12-31) — Stock Based Compensation: 15569000.00
VET balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2810989000.00
VET balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2810989000.00
VET income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -23890200.00
VET income_statement (annual, 2024-12-31) — Tax Provision: 26250000.00
VET income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
VET balance_sheet (annual, 2024-12-31) — Taxes Receivable: 0.00
VET balance_sheet (annual, 2024-12-31) — Total Assets: 6115576000.00
VET balance_sheet (annual, 2024-12-31) — Total Capitalization: 3774445000.00
VET balance_sheet (annual, 2024-12-31) — Total Debt: 1018447000.00
VET balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 2810989000.00
VET income_statement (annual, 2024-12-31) — Total Expenses: 1452280000.00
VET balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3304587000.00
VET balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 5533250000.00
VET balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 2640409000.00
VET balance_sheet (annual, 2024-12-31) — Total Tax Payable: 113715000.00
VET income_statement (annual, 2024-12-31) — Total Unusual Items: -159268000.00
VET income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -159268000.00
VET balance_sheet (annual, 2024-12-31) — Working Capital: -81852000.00
VET income_statement (quarterly, 2025-03-31) — +Operating Expense: 193480000.00
VET income_statement (quarterly, 2025-03-31) — +Total Revenue: 484968000.00
VET balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 544377000.00
VET balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 305955000.00
VET balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 51156000.00
VET income_statement (quarterly, 2025-03-31) — Basic Average Shares: 154173000.00
VET income_statement (quarterly, 2025-03-31) — Basic EPS: 0.10
VET cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 131730000.00
VET cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -182119000.00
VET balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 56835000.00
VET balance_sheet (quarterly, 2025-03-31) — Capital Stock: 3899688000.00
VET balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 23528000.00
VET balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 23528000.00
VET cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -18521000.00
VET balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 5599000.00
VET balance_sheet (quarterly, 2025-03-31) — Cash Financial: 17929000.00
VET cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 865986000.00
VET cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -1255746000.00
VET cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 280384000.00
VET cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 33702000.00
VET cash_flow (quarterly, 2025-03-31) — Changes In Cash: -109376000.00
VET balance_sheet (quarterly, 2025-03-31) — Common Stock: 3899688000.00
VET cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -18521000.00
VET balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2881288000.00
VET cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -16576000.00
VET income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 194648000.00
VET balance_sheet (quarterly, 2025-03-31) — Current Assets: 509726000.00
VET balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 718144000.00
VET cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -9016000.00
VET cash_flow (quarterly, 2025-03-31) — Deferred Tax: -9016000.00
VET cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 176388000.00
VET balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 81835000.00
VET income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 155609000.00
VET income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.10
VET income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 14953000.00
VET balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 20043000.00
VET income_statement (quarterly, 2025-03-31) — EBIT: 45982000.00
VET income_statement (quarterly, 2025-03-31) — EBITDA: 222370000.00
VET cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 1174000.00
VET cash_flow (quarterly, 2025-03-31) — End Cash Position: 23528000.00
VET balance_sheet (quarterly, 2025-03-31) — Financial Assets: 4392000.00
VET cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 865986000.00
VET balance_sheet (quarterly, 2025-03-31) — Finished Goods: 48561000.00
VET cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 98265000.00
VET cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 13675000.00
VET income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -36073000.00
VET balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 208518000.00
VET income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 35666000.00
VET balance_sheet (quarterly, 2025-03-31) — Gross PPE: 6425868000.00
VET income_statement (quarterly, 2025-03-31) — Gross Profit: 290320000.00
VET balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 40227000.00
VET cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 29889000.00
VET balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 105898000.00
VET income_statement (quarterly, 2025-03-31) — Interest Expense: 32979000.00
VET income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 32979000.00
VET cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 21409000.00
VET balance_sheet (quarterly, 2025-03-31) — Inventory: 48561000.00
VET balance_sheet (quarterly, 2025-03-31) — Invested Capital: 4755321000.00
VET cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1255746000.00
VET balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 78536000.00
VET balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 78536000.00
VET cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1306809000.00
VET balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 56835000.00
VET balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1874033000.00
VET balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1930868000.00
VET cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 1306809000.00
VET cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -403296000.00
VET balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 1092293000.00
VET cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: -1084456000.00
VET cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -16576000.00
VET balance_sheet (quarterly, 2025-03-31) — Net Debt: 1850505000.00
VET cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 35899000.00
VET income_statement (quarterly, 2025-03-31) — Net Income: 14953000.00
VET income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 14953000.00
VET income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 3849000.00
VET income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 11104000.00
VET income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 14953000.00
VET income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 3849000.00
VET cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 14953000.00
VET income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 14953000.00
VET income_statement (quarterly, 2025-03-31) — Net Interest Income: -32979000.00
VET cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 0.00
VET cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 903513000.00
VET cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 903513000.00
VET income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -32979000.00
VET cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -2430000.00
VET cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 10829000.00
VET balance_sheet (quarterly, 2025-03-31) — Net PPE: 6425868000.00
VET cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -182119000.00
VET balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2881288000.00
VET balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 65248000.00
VET balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 379342000.00
VET balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 65248000.00
VET balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 379342000.00
VET income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 258443000.00
VET income_statement (quarterly, 2025-03-31) — Normalized Income: 34511050.00
VET cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 280384000.00
VET cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 49574000.00
VET income_statement (quarterly, 2025-03-31) — Operating Income: 96840000.00
VET income_statement (quarterly, 2025-03-31) — Operating Revenue: 484968000.00
VET balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 154177000.00
VET balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 47826000.00
VET balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 208518000.00
VET income_statement (quarterly, 2025-03-31) — Other Gand A: 29735000.00
VET income_statement (quarterly, 2025-03-31) — Other Income Expense: -50858000.00
VET cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 8852000.00
VET income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -14785000.00
VET income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 157814000.00
VET balance_sheet (quarterly, 2025-03-31) — Payables: 670318000.00
VET balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 670318000.00
VET balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 76314000.00
VET income_statement (quarterly, 2025-03-31) — Pretax Income: 13003000.00
VET balance_sheet (quarterly, 2025-03-31) — Properties: 373864000.00
VET cash_flow (quarterly, 2025-03-31) — Purchase Of Business: -1084456000.00
VET cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
VET cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -182119000.00
VET balance_sheet (quarterly, 2025-03-31) — Receivables: 321096000.00
VET income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 194648000.00
VET income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 176388000.00
VET cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -403296000.00
VET cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -16576000.00
VET balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1278074000.00
VET income_statement (quarterly, 2025-03-31) — Salaries And Wages: 5931000.00
VET income_statement (quarterly, 2025-03-31) — Selling General And Administration: 35666000.00
VET balance_sheet (quarterly, 2025-03-31) — Share Issued: 154177000.00
VET cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 5931000.00
VET balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2881288000.00
VET balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2881288000.00
VET income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -5410950.00
VET income_statement (quarterly, 2025-03-31) — Tax Provision: 9154000.00
VET income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.15
VET balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 15141000.00
VET balance_sheet (quarterly, 2025-03-31) — Total Assets: 7083770000.00
VET balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4755321000.00
VET balance_sheet (quarterly, 2025-03-31) — Total Debt: 1930868000.00
VET balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2881288000.00
VET income_statement (quarterly, 2025-03-31) — Total Expenses: 388128000.00
VET balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4202482000.00
VET balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 6574044000.00
VET balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3484338000.00
VET balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 105898000.00
VET income_statement (quarterly, 2025-03-31) — Total Unusual Items: -36073000.00
VET income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -36073000.00
VET balance_sheet (quarterly, 2025-03-31) — Working Capital: -208418000.00
VET income_statement (quarterly, 2025-06-30) — +Operating Expense: 205249000.00
VET income_statement (quarterly, 2025-06-30) — +Total Revenue: 472306000.00
VET balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 403525000.00
VET balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 279469000.00
VET balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 36351000.00
VET cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 372386000.00
VET balance_sheet (quarterly, 2025-06-30) — Assets Held For Sale Current: 598435000.00
VET income_statement (quarterly, 2025-06-30) — Basic Average Shares: 154342000.00
VET income_statement (quarterly, 2025-06-30) — Basic EPS: -1.51
VET cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 23528000.00
VET cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -115489000.00
VET balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 52776000.00
VET balance_sheet (quarterly, 2025-06-30) — Capital Stock: 3899500000.00
VET balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 69187000.00
VET balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 69187000.00
VET cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -20043000.00
VET balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 375000.00
VET balance_sheet (quarterly, 2025-06-30) — Cash Financial: 68812000.00
VET cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 104162000.00
VET cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -198989000.00
VET cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 140467000.00
VET cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -110825000.00
VET cash_flow (quarterly, 2025-06-30) — Changes In Cash: 45640000.00
VET balance_sheet (quarterly, 2025-06-30) — Common Stock: 3899500000.00
VET balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2693625000.00
VET cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -6323000.00
VET income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 223501000.00
VET balance_sheet (quarterly, 2025-06-30) — Current Assets: 1171777000.00
VET balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 603527000.00
VET cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -20997000.00
VET cash_flow (quarterly, 2025-06-30) — Deferred Tax: -20997000.00
VET cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 184167000.00
VET balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 80677000.00
VET income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 155778000.00
VET income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.51
VET income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -233458000.00
VET balance_sheet (quarterly, 2025-06-30) — Dividends Payable: 20022000.00
VET income_statement (quarterly, 2025-06-30) — EBIT: 165292000.00
VET income_statement (quarterly, 2025-06-30) — EBITDA: 349459000.00
VET cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 19000.00
VET cash_flow (quarterly, 2025-06-30) — End Cash Position: 69187000.00
VET balance_sheet (quarterly, 2025-06-30) — Financial Assets: 15062000.00
VET cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 104162000.00